Calcipotriol/Betamethasone Orifarm

Calcipotriol/Betamethasone Orifarm is a topical medication combining calcipotriol and betamethasone for skin conditions. This dual-action treatment is designed to target inflammation and scaling associated with psoriasis.

Calcipotriol/Betamethasone Orifarm is primarily used for the treatment of plaque psoriasis. Calcipotriol works to normalize skin cell production, while betamethasone reduces inflammation and itching. This combination is often recommended for moderate to severe psoriasis, helping to clear affected areas and improve skin appearance.

When applied to the skin, Calcipotriol/Betamethasone Orifarm may reduce redness, scaling, and itching. Users often notice improvements in skin texture and a reduction in plaque formation. Some individuals may experience temporary skin irritation or dryness at the application site.

This medication is for external use only and should not be applied to broken or infected skin. Avoid contact with the eyes, mouth, and mucous membranes. Prolonged use or overapplication should be avoided unless directed by a healthcare professional. Always follow the instructions provided with the product.

Calcipotriol/Betamethasone Orifarm may interact with other topical treatments or medications applied to the same area. It is advisable to consult a healthcare provider before using this product alongside other skin treatments. Additionally, some individuals may experience increased sensitivity to sunlight while using this medication.